AIM ImmunoTech Future Growth
Future criteria checks 2/6
AIM ImmunoTech is forecast to grow earnings and revenue by 6.5% and 66.1% per annum respectively while EPS is expected to grow by 11% per annum.
Key information
6.5%
Earnings growth rate
11.0%
EPS growth rate
Biotechs earnings growth | 37.8% |
Revenue growth rate | 66.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 21 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4 | -16 | N/A | N/A | 2 |
12/31/2025 | 2 | -16 | N/A | -6 | 3 |
12/31/2024 | 0 | -18 | N/A | -8 | 3 |
6/30/2024 | 0 | -28 | -24 | -23 | N/A |
3/31/2024 | 0 | -31 | -23 | -22 | N/A |
12/31/2023 | 0 | -29 | -22 | -21 | N/A |
9/30/2023 | 0 | -21 | -18 | -18 | N/A |
6/30/2023 | 0 | -19 | -17 | -17 | N/A |
3/31/2023 | 0 | -19 | -17 | -17 | N/A |
12/31/2022 | 0 | -19 | -16 | -16 | N/A |
9/30/2022 | 0 | -21 | -16 | -16 | N/A |
6/30/2022 | 0 | -18 | -15 | -14 | N/A |
3/31/2022 | 0 | -19 | -14 | -14 | N/A |
12/31/2021 | 0 | -19 | -15 | -14 | N/A |
9/30/2021 | 0 | -17 | -12 | -11 | N/A |
6/30/2021 | 0 | -17 | -11 | -11 | N/A |
3/31/2021 | 0 | -14 | -11 | -10 | N/A |
12/31/2020 | 0 | -14 | -11 | -10 | N/A |
9/30/2020 | 0 | -12 | -10 | -10 | N/A |
6/30/2020 | 0 | -11 | -10 | -9 | N/A |
3/31/2020 | 0 | -10 | -11 | -11 | N/A |
12/31/2019 | 0 | -9 | -9 | -9 | N/A |
9/30/2019 | 0 | -10 | -9 | -9 | N/A |
6/30/2019 | 0 | -10 | -10 | -10 | N/A |
3/31/2019 | 0 | -10 | -10 | -10 | N/A |
12/31/2018 | 0 | -10 | -11 | -11 | N/A |
9/30/2018 | 0 | -10 | -9 | -9 | N/A |
6/30/2018 | 0 | -8 | -8 | -8 | N/A |
3/31/2018 | 0 | -8 | N/A | -7 | N/A |
12/31/2017 | 0 | -8 | N/A | -8 | N/A |
9/30/2017 | 0 | -7 | N/A | -9 | N/A |
6/30/2017 | 0 | -9 | N/A | -10 | N/A |
3/31/2017 | 0 | -8 | N/A | -9 | N/A |
12/31/2016 | 0 | -8 | N/A | -7 | N/A |
9/30/2016 | 0 | -9 | N/A | -9 | N/A |
6/30/2016 | 0 | -10 | N/A | -9 | N/A |
3/31/2016 | 0 | -14 | N/A | -13 | N/A |
12/31/2015 | 0 | -15 | N/A | -16 | N/A |
9/30/2015 | 0 | -17 | N/A | -17 | N/A |
6/30/2015 | 0 | -17 | N/A | -17 | N/A |
3/31/2015 | 0 | -17 | N/A | -15 | N/A |
12/31/2014 | 0 | -17 | N/A | -14 | N/A |
9/30/2014 | 0 | -16 | N/A | -13 | N/A |
6/30/2014 | 0 | -17 | N/A | -13 | N/A |
3/31/2014 | 0 | -16 | N/A | -14 | N/A |
12/31/2013 | 0 | -16 | N/A | -17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0A4Y is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0A4Y is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0A4Y is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0A4Y's revenue (66.1% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: 0A4Y's revenue (66.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0A4Y's Return on Equity is forecast to be high in 3 years time